These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 14670915)
1. HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Jacolot S; Le Gac G; Scotet V; Quere I; Mura C; Ferec C Blood; 2004 Apr; 103(7):2835-40. PubMed ID: 14670915 [TBL] [Abstract][Full Text] [Related]
2. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468 [TBL] [Abstract][Full Text] [Related]
3. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene. Altès A; Bach V; Ruiz A; Esteve A; Felez J; Remacha AF; Sardà MP; Baiget M Ann Hematol; 2009 Oct; 88(10):951-5. PubMed ID: 19214511 [TBL] [Abstract][Full Text] [Related]
10. Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice. Nicolas G; Andrews NC; Kahn A; Vaulont S Blood; 2004 Apr; 103(7):2841-3. PubMed ID: 14656876 [TBL] [Abstract][Full Text] [Related]
11. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis]. Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139 [TBL] [Abstract][Full Text] [Related]
13. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants. Barton JC; Lafreniere SA; Leiendecker-Foster C; Li H; Acton RT; Press RD; Eckfeldt JH Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796 [TBL] [Abstract][Full Text] [Related]
14. Hemojuvelin and hepcidin genes sequencing in Brazilian patients with primary iron overload. de Lima Santos PC; Pereira AC; Cançado RD; Schettert IT; Hirata RD; Hirata MH; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM Genet Test Mol Biomarkers; 2010 Dec; 14(6):803-6. PubMed ID: 21039223 [TBL] [Abstract][Full Text] [Related]
16. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway. Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W Digestion; 2005; 72(1):25-32. PubMed ID: 16103673 [TBL] [Abstract][Full Text] [Related]
17. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179 [TBL] [Abstract][Full Text] [Related]
19. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868 [TBL] [Abstract][Full Text] [Related]
20. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis. Shukla P; Julka S; Bhatia E; Shah S; Nagral A; Aggarwal R Natl Med J India; 2006; 19(1):20-3. PubMed ID: 16570681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]